| Summary: | Colorectal carcinoma (CRC) is a common cause of cancer-related death and tumors with microsatellite instability (MSI) and p53 mutations have been shown to be resistant to chemotherapy with 5-fluorouracil (5-FU). Therefore, it is essential to find compounds that could contribute to treatment efficacy by increasing the sensitivity to 5-FU. HCT15, a MSI human CRC derived cell line that harbours a p53 mutation, was incubated with the triterpenoid ursolic acid (UA) at a concentration that induces approximately 50% cell death (measured by PI stainning) after 48h. A synergistic enhancement of apoptosis was observed when co-incubating 5-FU with UA (measured by TUNEL assay). UA induction of apoptosis was totally abolished by the JNK inhibitor SP600125 (SP), but not by the caspase inhibitor zVAD-fmk. Apoptosis did not account for all the observed cell death induced by UA. Thus, we asked whether UA was also inducing autophagy. We observed that UA induced accumulation of autophagossomes (using fluorescent dyes) as well as of LC3-II (assessed by western blot), which was also significantly inhibited by SP. These results suggest that UA induction of apoptosis and autophagy is JNK dependent. A decrease in mutated p53 and phospho mTOR, which are associated with an induction of autophagy, were also observed. In conclusion, UA showed anticancer activity by inducing apoptosis and autophagy, which was JNK-dependent in HCT15 cells. In addition, in these resistant cells, UA synergistically cooperate with 5-FU to induce cell death.
|
|---|